Ministry of Health ServicesGoverment of British Columbia
Pharmacare Program
| Home | SA Criteria | SA Forms | RDP | LCA |
Limited Coverage Drugs - Special Authority Criteria

Generic Name / Strength / Form
valsartan

Criteria Approval Period
Person identified as experiencing intractable cough or angioedema on an Angiotensin Converting Enzyme Inhibitor (ACE-I). Indefinite

Practitioner Exemptions

  • No practitioner exemptions

Special Notes

  • Individuals requiring a diuretic combination product must satisfy the same criteria.

Online Forms (PDF)
Click on the link to complete a special authority request form.

PDF Format

Some documents on this Web site are in PDF format and require a PDF reader. If you do not have Adobe Acrobat Reader Version 7.0 or the most recent version of another PDF reader, you can download Adobe Acrobat Reader by selecting the 'Get Acrobat Reader' icon. Get Acrobat Reader Icon

Back To Top

Last Revised: July 10, 2007

blank
    space for alignment
Go to TopGo to CopyrightGo to DisclaimerGo to Privacy StatementGo to Feedback Form
blank space for alignment blank space for alignment blank
    space for alignment blank space for alignment blank space for alignment blank space for alignment